The nurse is caring for a client who is being treated for peptic ulcer disease. Which medication should the client be taught to avoid?

A) Increase dosing with a large meal:
Increasing the dosing with a large meal may not be appropriate as it could lead to overdosing and potential side effects. The dosage of pancrelipase should be determined by the healthcare provider based on the individual's needs and response to treatment. There's no evidence to support the need for increased dosing with larger meals.

B) Take the medication at least 2 hours prior to meals:
Taking the medication prior to meals may not be effective as the enzymes will not be available when food is consumed, which defeats the purpose of enzyme replacement therapy. The enzymes need to be present simultaneously with the food to aid in digestion. Waiting 2 hours before meals would mean the enzymes are not available when needed.

C) Take the medication with meals.
Pancrelipase, such as Cotazym, is a pancreatic enzyme replacement therapy used to aid in the digestion of fats, proteins, and carbohydrates in individuals with pancreatic insufficiency. Taking the medication with meals is crucial because it helps ensure that the enzymes are available to aid in the digestion of food. Without proper enzyme supplementation during meals, individuals with pancreatic insufficiency may experience malabsorption, leading to nutritional deficiencies and gastrointestinal symptoms.

D) Decrease fluid intake:
Decreasing fluid intake is not appropriate as it could lead to dehydration and may not have any significant impact on the efficacy of pancrelipase. In fact, adequate fluid intake is important for digestion and overall health. There's no indication that fluid intake needs to be decreased when taking pancrelipase.

A) Lowered heart rate:
Dopamine typically increases heart rate as it acts on beta-adrenergic receptors in the heart, leading to increased cardiac contractility and chronotropy. However, at low doses, the effect on heart rate may be minimal compared to higher doses.

B) Decreased conduction through the AV node:
Dopamine may have minimal effects on conduction through the atrioventricular (AV) node, especially at low doses. It primarily acts on adrenergic receptors to increase cardiac contractility and heart rate.

C) Increased urine output.
Dopamine is a medication commonly used to treat shock by improving cardiac output and blood pressure. At low doses, dopamine primarily acts on dopamine receptors in the renal blood vessels, causing vasodilation and increased renal blood flow. This increased renal blood flow leads to increased glomerular filtration rate (GFR) and urine output. Therefore, increased urine output is an expected effect of dopamine infusion at low doses in the treatment of shock.

D) Vasoconstriction of renal blood vessels:
At low doses, dopamine primarily acts on dopamine receptors in the renal blood vessels, causing vasodilation and increased renal blood flow. Vasoconstriction of renal blood vessels is more commonly associated with higher doses of dopamine or with other vasopressor medications such as norepinephrine or phenylephrine.